Journal Article

Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells

Matas-Rico, Elisa, Stijf-Bultsma, Yvette, van den Broek, Bram, Sidenius, Nicolai, Moolenaar, Wouter H, Leyton-Puig, Daniela, van Veen, Michiel, van de Wetering, Koen, Jalink, Kees, Perrakis, Anastassis, Kedziora, Katarzyna M, De Lorenzi, Valentina

2017

Overview

The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior. Every process in the body, from how cells divide to how they move around, is tightly regulated. For example, cells only migrate when they receive the correct signals from their environment. These signals are recognised by receptor proteins that sit on the cell surface and connect the outside signal with the cell’s response. However, in cancer cells, these processes are out of control, which is why cancer cells can grow very quickly or spread to many different parts of the body. One important receptor protein is the urokinase receptor, which helps to reorganize the tissue, for example, when wounds heal, but also enables cancer cells to grow and spread. A special feature of urokinase receptor is the way it is connected to the cell surface, namely through a molecule that acts as an anchor, called the GPI anchor. The urokinase receptor and some other GPI-anchored proteins can be released from their anchor. However, until now it was not clear why and how the urokinase receptor is released from cells, or how losing the receptor affects the cell. Now, van Veen, Matas-Rico et al. studied breast cancer cells, and discovered that an enzyme called GDE3 cuts the urokinase receptor off its GPI anchor to release the receptor from the cells. However, when breast cancer cells shed the urokinase receptor, they also lost the receptor from the cell surface in specific areas. As a result, the receptor could not work anymore. When breast cancer cells were experimentally modified to produce high levels of GDE3, the cancer cells became less mobile and aggressive. Van Veen, Matas-Rico et al. then implanted ‘normal’ breast cancer cells, and breast cancer cells with extra GDE3 into mice, and observed that the tumors of mice with additional GDE3 grew less quickly. Moreover, breast cancer patients with high levels of GDE3 tend to live longer than patients with low levels of GDE3. These results suggest that the enzyme GDE3 can suppress tumor growth. These findings uncover a new way how cells can alter their behavior, namely by cleaving GPI anchors at the cell surface. Future experiments will need to address how GDE3 itself is controlled, and if it releases other GPI-anchored proteins from cells. Once we know how to increase GDE3 activity in tumor cells, the new knowledge could one day lead to therapies to help patients with cancer.

• Publisher: eLife Science Publications, Ltd,eLife Sciences Publications Ltd,eLife Sciences Publications, Ltd
• Subject: Analysis / Animals / Breast cancer / Breast Neoplasms - genetics / Breast Neoplasms - metabolism / Breast Neoplasms - pathology / Cancer Biology / Cancer cells / Cancer research / Cell Adhesion / Cell Biology / Cell Line, Tumor / Cell Proliferation / Cell surface / Cell Transformation, Neoplastic - genetics / Cell Transformation, Neoplastic - metabolism / Cell Transformation, Neoplastic - pathology / Clustered Regularly Interspaced Short Palindromic Repeats / Down-regulation / Enzymes / Extracellular matrix / Female / Flow cytometry / GDE3 / Gene Expression Regulation, Neoplastic / Gene Knockout Techniques - methods / Glycerophosphodiester phosphodiesterase / Glycosylphosphatidylinositol / HEK293 Cells / Humans / Hydrolysis / Integrins / Isoenzymes - genetics / Isoenzymes - metabolism / Ligands / Localization / Medical research / Mice / Mice, Nude / Microscopy / Models, Molecular / Motility / Neoplasm Transplantation / Phospholipase C / Phospholipases / Phosphoric Diester Hydrolases - genetics / Phosphoric Diester Hydrolases - metabolism / Physiology / Proteases / Proteins / Receptors, Urokinase Plasminogen Activator - antagonists & inhibitors / Receptors, Urokinase Plasminogen Activator - genetics / Receptors, Urokinase Plasminogen Activator - metabolism / RNA, Small Interfering - genetics / RNA, Small Interfering - metabolism / Rodents / Scientific equipment industry / Signal Transduction / Statistical analysis / Thrombolytic drugs / Tumor Burden / Tumors / U-Plasminogen activator / Vitronectin / Vitronectin - genetics / Vitronectin - metabolism / Xenografts